Amira Ghazali, MD
Surgery · St Johnsbury, VTNPI 1740505858
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $396 and has fallen 78.5% since, to $85 in 2025.
Across 79 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$228
- Organogenesis Inc.$170
- Amgen$115
- AstraZeneca$76
- Regeneron Healthcare Solutions, Inc.$71
- Lilly USA, LLC$69
- plus $659 from 24 others
What the payments were for
- Food & beverage$1,387100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 14 | $228 |
| Organogenesis Inc. | 9 | $170 |
| Amgen | 6 | $115 |
| AstraZeneca | 4 | $76 |
| Regeneron Healthcare Solutions, Inc. | 4 | $71 |
| Lilly USA, LLC | 4 | $69 |
| Daiichi Sankyo Inc. | 3 | $64 |
| Boehringer Ingelheim | 4 | $58 |
| Electromed, Inc. | 4 | $56 |
| Smith+Nephew | 3 | $53 |
| Vertex | 2 | $45 |
| Mylan Specialty L.p. | 2 | $42 |
| AbbVie | 2 | $39 |
| Merck | 2 | $35 |
| CSL Behring | 1 | $28 |
| Dilon Technologies, Inc. | 1 | $23 |
| Grifols USA, LLC | 1 | $20 |
| Genentech USA, Inc. | 1 | $20 |
| UCB, Inc. | 1 | $19 |
| Baxter Healthcare | 1 | $18 |
| Axonics, Inc. | 1 | $18 |
| Circassia Inc. | 1 | $18 |
| Philips North America LLC | 1 | $17 |
| Leica Microsystems Inc. | 1 | $17 |
| Medline Industries LP | 1 | $14 |
| Innocoll Pharmaceuticals Limited | 1 | $14 |
| Convatec Inc. | 1 | $13 |
| GSK | 1 | $12 |
| Focal Therapeutics, Inc. | 1 | $12 |
| Endogastric Solutions, Inc | 1 | $7 |
How this compares
$1,387 in reported general payments places this provider in the 80th percentile of 31 surgery providers in Vermont.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 48 | $3,146 |
| Pantoprazole Sodium | 168 | $2,441 |
| Esomeprazole Magnesium | 16 | $261 |
| Ondansetron Hcl | 20 | $199 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $126 |
Paid to pharmacies, not to this prescriber.
Other surgery in St Johnsbury
- Conor O'NeillBurlington$17K
- Ralph BolmanBurlington$14K
- Benjamin BernardBennington$6K
- Victoria EdwardsRandolph$3K
- Andrew ErbBurlington$2K
- Sarah Kelso-O'brienBurlington$2K
- Sarah WatermanMorrisville$1K
- Solomon FeuerwerkerBurlington$1K
- Edward BorrazzoBurlington$798
- Gina LambBennington$746
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.